The bill would strengthen prescription drug monitoring programs and curb manufacturing quotas for opioids.

The agency outlines an expanded list of outcomes drug companies should consider when testing medications used to treat addiction.

The agency is seeking to lower costs and reduce paperwork burdens for beneficiaries and physicians.

The CMS administrator is seeking public comment on ways to relax "burdensome" provisions of the self-referral law.

The programs will help connect those suffering from addiction to much-needed community resources.

The federal crackdown recovered $2.4 billion in fiscal year 2017.

Patients receiving nonopioid medications reported less pain intensity than those receiving opioids.

The hefty budget bill delivers healthcare compromises that industry leaders have long requested.

More neutral adjustments and few upward adjustments for physicians as the Value Modifier program ends and is replaced by alternative payment models.